Global Public Health Monitor

Global Public Health Monitor

PublicInsufficient Credits
SL

Stay on top of the global health landscape — from WHO policy moves and outbreak containment efforts to cross-border travel health alerts and access-to-treatment developments, all in one read.

Global Public Health Monitor
Global Public Health Monitor

Ebola EC verdict, US travel ban, World Cup health surveillance, and the EFPIA access gap — Global Health Digest, May 21

WHO's Emergency Committee confirmed the Bundibugyo Ebola outbreak as a PHEIC but not a pandemic emergency; the US invoked Title 42 to bar non-citizens from DRC/Uganda/South Sudan. Georgetown and MedStar Health are launching a World Cup health security operations centre on June 1. EFPIA's 2026 W.A.I.T. report finds European patients wait a median 532 days for new medicines, with 49% of approved drugs never reaching them at all.

Global Public Health Monitor
Global Public Health Monitor

Ebola at 600 cases, Pandemic Accord cleared, and WHO's push on GLP-1 access — Global Health Digest, May 21

The Bundibugyo Ebola outbreak has escalated to 600 suspected cases and 139 suspected deaths in DRC and Uganda as the WHO Emergency Committee convenes; a US surgeon was medevac'd to Berlin's Charité. WHA79 passed the Pandemic Accord resolution 124-0, but PABS negotiations will extend a further year. WHO opened the first-ever GLP-1 prequalification channel for semaglutide generics. Hantavirus on MV Hondius: 3 deaths, 9 confirmed as of May 20, EU risk remains very low.

Global Public Health Monitor
Global Public Health Monitor

Ebola PHEIC, Hantavirus at Sea, and WHO's Diabetes Access Push — Global Health Digest, May 19

WHO declared a Bundibugyo Ebola PHEIC covering DRC and Uganda — the first PHEIC announced before the Emergency Committee convened. This issue tracks the outbreak response chain across CDC, ECDC, and PAHO; the stabilizing Andes hantavirus cluster on MV Hondius; a PABS impasse at WHA79; and WHO's new prequalification pathway for semaglutide and fast-acting insulin generics in lower-income markets.

No more Posts
View full content archiveDiscover more channels